image
Phibro Animal Health Corporation PAHC
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 24.46
-1.77 %
$ 991 M
Market Cap
56.88
P/E
CASH FLOW STATEMENT
87.6 M OPERATING CASH FLOW
558.11%
Growth Rates
1Year 558.11%
3Years 21.94%
5Years 13.18%
7Years -1.65%
10Years 62.07%
-48.2 M INVESTING CASH FLOW
34.89%
Growth Rates
1Year 34.89%
3Years -37.40%
5Years -27.81%
7Years -11.93%
10Years -9.52%
-6.77 M FINANCING CASH FLOW
-25.08%
Growth Rates
1Year -25.08%
3Years 26.43%
5Years -10.51%
7Years 25.62%
10Years -9.22%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Phibro Animal Health Corporation
image
Net Income 2.42 M
Depreciation & Amortization 36.2 M
Capital Expenditures -41.2 M
Stock-Based Compensation 475 K
Change in Working Capital 33.1 M
Others 50.4 M
Free Cash Flow 46.4 M

Cash Flow

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012 Jun-2011 Jun-2007 Jun-2006 Jun-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000
OPERATING CASH FLOW
Net Income 2.4 32.6 49.2 54.4 33.6 54.7 64.9 64.6 82.7 60.3 (3.1) 24.9 7.0 (12.9) (6.7) (13.1) (22.1) 12.9 (17.6) (51.8) (14.9) 10.1
Depreciation & Amortization 36.2 34.0 32.7 31.9 32.3 27.6 26.9 26.0 23.5 21.6 21.5 19.0 17.5 16.7 10.7 14.0 18.1 10.7 11.0 12.4 10.4 11.9
Deferred Income Tax (7.8) (2.8) (0.8) (2.2) 8.1 (0.1) 6.4 28 K (22.2) 4.8 1.3 (12.0) (2.4) 0.7 1.2 (0.5) (1.0) 0.3 6.5 11.2 (5.7) 1.4
Stock Based Compensation 0.5 0 0 1.1 2.3 2.3 0.3 0 0 0 73 K 0.2 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 23.3 1.1 (4.8) (7.0) (3.3) (1.3) 6.3 127.7 7.1 2.4 0.9 0.5 1.3 3.0 (6.8) (24.0) (46.5) 20.4 58.3 29.4 (56.5) (15.3)
Change in Working Capital 33.1 (41.1) (44.6) (29.9) (13.7) (35.9) (33.9) 1.4 (46.1) (17.0) (28.2) (34.8) 5.2 (9.0) (3.2) 24.4 45.3 (41.4) (23.5) (5.9) 79.9 (16.0)
Cash From Operations 87.6 13.3 31.6 48.3 59.3 47.2 70.0 98.4 37.2 68.7 (0.7) 0.4 32.0 (4.7) (4.7) 0.8 (6.2) 2.9 34.7 (4.8) 13.1 (7.9)
INVESTING CASH FLOW
Capital Expenditures (41.2) (51.8) (37.0) (29.3) (34.0) (29.9) (18.5) (20.9) (36.4) (20.1) (19.8) (19.9) (14.8) (21.6) (10.6) (15.1) (7.5) (6.1) (8.5) (8.5) (6.6) (22.6)
Other Items (7.0) (22.2) 14.5 10.7 (86.3) 15.8 (66.1) (1.0) (46.4) (14.4) 0.4 (17.4) (2.9) 2.2 (1.3) 9.8 7.5 15.2 4.5 (8.8) (33.5) 18.5
Cash From Investing Activities (48.2) (74.0) (22.6) (18.6) (120.4) (14.1) (84.6) (21.9) (82.8) (34.5) (19.4) (37.3) (17.7) (19.5) (11.9) (5.3) 20 K 9.1 (4.0) (17.4) (40.1) (4.1)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.6) 0 (26.4) 0 0 0 45.0 0
Total Debt Repaid 12.7 42.7 40.6 5.4 60.4 13.4 (1.4) (39.5) 62.1 (1.1) (80.1) 14.8 (8.2) 68.3 0 0 0 0 0 0 0 0
Dividends Paid (19.4) (19.4) (19.4) (19.4) (19.4) (18.6) (16.1) (15.8) (15.7) (15.6) (25.0) (3.0) 0 (50.0) 0 0 0 0 0 0 0 0
Other Financing Activities 31 K 3.7 (4.8) (2.9) 0 0 0 (3.9) 0 0 (4.6) (0.9) 0 (8.2) 19.9 (0.5) 14.2 (17.8) (26.4) 13.7 39.9 11.3
Cash From Financing Activities (6.8) 27.0 16.3 (17.0) 40.9 (4.1) (11.8) (53.7) 50.4 (15.4) 4.8 10.9 (8.2) 10.2 19.9 (0.5) 14.2 (17.8) (26.4) 13.7 39.9 11.3
CHANGE IN CASH
Net Change In Cash 29.3 (33.0) 24.0 13.9 (21.2) 28.4 (26.9) 22.5 4.4 17.4 (15.5) (26.5) 5.3 (14.1) 3.3 (4.9) 8.0 (5.6) 4.8 (8.4) 12.4 (0.6)
FREE CASH FLOW
Free Cash Flow 46.4 (38.5) (5.4) 19.0 25.3 17.3 51.5 77.5 0.9 48.6 (20.6) (19.5) 17.2 (26.3) (15.3) (14.3) (13.7) (3.3) 26.1 (13.3) 6.5 (30.5)